CANCER CONTROL PLANNING
CANCER CONTROL 2014 23
2005-2010. He has a PhD in epidemiology from the London
School of Hygiene and Tropical Medicine, and degrees in
statistics from the University of Aberdeen and the University of
Leicester. His areas of research are in the descriptive
epidemiology of cancer, including the estimation of the global
cancer burden, the analysis and interpretation of time trends of
cancer and future predictions, and their linkages with human
development transitions. There is an ever-pressing need for a
sustainable expansion of the coverage and quality of cancer
registries in less developed countries to improve cancer
surveillance and planning. A major interest and remit of the
Section is therefore in support of the implementation and
development of population-based cancer registries in these
settings through the Global Initiative for Cancer Registration in
LMIC (GICR, http://www.gicr.fr).
References
1. World Health Organization. Global status report on noncommunicable diseases 2010.
Geneva: World Health Organization, 2011.
2. Chestnov O, Mendis S, Bettcher D. A milestone in the response to non-communicable
diseases. Lancet 2013;382:481-2.
3. United Nations DoEaSAPD. Changing Levels and Trends in Mortality: the role of
patterns of death by cause. United Nations publication, ST/ESA/SER.A/318; 2012.
4. Omran AR. The epidemiologic transition. A theory of the epidemiology of population
change. Milbank Mem Fund Q 1971;49:509-38.
5. Maule M, Merletti F. Cancer transition and priorities for cancer control. Lancet Oncol
2012;13:745-6.
6. WHO. Scaling up action against noncommunicable diseases: how much will it cost?
Geneva: WHO; 2011.
7. Parkin DM, Nambooze S, Wabwire-Mangen F, Wabinga HR. Changing cancer incidence
in Kampala, Uganda, 1991-2006. Int J Cancer 2010;126:1187-95.
8. Chokunonga E, Borok MZ, Chirenje ZM, Nyakabau AM, Parkin DM. Trends in the
incidence of cancer in the black population of Harare, Zimbabwe 1991-2010. Int J
Cancer 2013;133:721-9.
9. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM,
Forman D, Bray F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worlwide:
IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research
on Cancer, 2013.
10.
United Nations Development programme. Human Development Report 2013. The
Rise of the South: Human Progress in a Diverse World. New York: UNDP; 2013.
11.
Franceschi S, Wild CP. Meeting the global demands of epidemiologic transition - the
indispensable role of cancer prevention. Mol Oncol 2013;7:1-13.
12.
Cogliano VJ, Baan R, Straif K, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V,
brahim-Tallaa L, Guha N, Freeman C, Galichet L, Wild CP. Preventable exposures
associated with human cancers. J Natl Cancer Inst 2011;103:1827-39.
13.
IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 100A:
A Review of Human Carcinogens: Pharmaceuticals. Lyon: International Agency for
Research on Cancer, 2012.
14.
IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 100B:
A Review of Human Carcinogens: Biological Agents. Lyon: International Agency for
Research on Cancer, 2012.
15.
IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 100C:
A Review of Human Carcinogens: Arsenic, Metals, Fibres, and Dusts. Lyon:
International Agency for Research on Cancer, 2012.
16.
IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 100D:
A Review of Human Carcinogens: Radiation. Lyon: International Agency for Research
on Cancer, 2012.
17.
IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 100E.
A Review of Human Carcinogens: Personal Habits and Indoor Combustions. Lyon:
International Agency for Research on Cancer, 2012.
18.
IARC. Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 100F:
A Review of Human Carcinogens: Chemical Agents and Related Occupations. Lyon:
International Agency for Research on Cancer, 2012.
19.
Day NE. The Armitage-Doll multistage model of carcinogenesis. Stat Med 1990;9:677-9.
20.
Bray F. Transitions in human development and the global cancer burden. World Cancer
Report 2014. Lyon, France: International Agency for Research on Cancer, 2014. p. 54-
68.
21.
Giovino GA, Mirza SA, Samet JM, Gupta PC, Jarvis MJ, Bhala N, Peto R, Zatonski W,
Hsia J, Morton J, Palipudi KM, Asma S. Tobacco use in 3 billion individuals from 16
countries: an analysis of nationally representative cross-sectional household surveys.
Lancet 2012;380:668-79.
22.
Mathers CD, Boerma T, Ma Fat D. Global and regional causes of death. Br Med Bull
2009;92:7-32.
23.
Bray F, Moller B. Predicting the future burden of cancer. Nat Rev Cancer 2006;6:63-74.
24.
Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the
Human Development Index (2008-2030): a population-based study. Lancet Oncol
2012;13:790-801.
25.
de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M. Global
burden of cancers attributable to infections in 2008: a review and synthetic analysis.
Lancet Oncol 2012;13:607-15.
26.
Sankaranarayanan R, Swaminathan R. Cancer survival in Africa, Asia, the Caribbean
and Central America (SurvCan), IARC Scientific Publication No 162. Lyon:
International Agency for Research on Cancer, 2011.
27.
IARC. IARC Handbooks of Cancer Prevention Volume 7: Breast Cancer Screening.
Lyon: IARC Press, 2002.
28.
IARC. IARC Handbooks of Cancer Prevention Volume 10: Cervix Cancer Screening.
Lyon: IARC Press, 2005.
29.
European Commission. European Guidelines for Quality Assurance in Colorectal
Cancer Screening, First Report ed. Luxembourg: European Communities, 2010.
30.
Franceschi S, Denny L, Irwin KL, Jeronimo J, Lopalco PL, Monsonego J, Peto J, Ronco G,
Sasieni P, Wheeler CM. Eurogin 2010 roadmap on cervical cancer prevention. Int J
Cancer 2011;128:2765-74.
31.
WHO. WHO guidelines for screening and treatment of precancerous lesions for
cervical cancer prevention. Geneva: WHO; 2013.
32.
Jamison DT, Summers LH, Alleyne G, Arrow KJ, Berkley S, Binagwaho A, Bustreo F,
Evans D, Feachem RG, Frenk J, Ghosh G, Goldie SJ, et al. Global health 2035: a world
converging within a generation. Lancet 2013;382:1898-955.
33.
Mendis S, Al Bashir, I, Dissanayake L, Varghese C, Fadhil I, Marhe E, Sambo B, Mehta F,
Elsayad H, Sow I, Algoe M, Tennakoon H, et al. Gaps in capacity in primary care in lowresource settings for implementation of essential noncommunicable disease
interventions. Int J Hypertens 2012;2012:584041.
34.
Beral V, Alexander M, Duffy S, Ellis IO, Given-Wilson R, Holmberg L, Moss SM, Ramirez
A, Reed MW, Rubin C, Whelehan P, Wilson R, et al. The number of women who would
need to be screened regularly by mammography to prevent one death from breast
cancer. J Med Screen 2011;18:210-2.
35.
Harford JB. Breast-cancer early detection in low-income and middle-income countries:
do what you can versus one size fits all. Lancet Oncol 2011;12:306-12.